Related Experiment Video
Updated: May 26, 2026
08:05
Production and Characterization of Human Macrophages from Pluripotent Stem Cells
Published on: April 16, 2020
Human regulatory macrophages as a cell-based medicinal product
James A Hutchinson1, Paloma Riquelme, Edward K Geissler
1Department of Surgery, Laboratory for Transplantation Research, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, Regensburg, Germany. james.hutchinson@klinik.uni-regensburg.de
Current Opinion in Organ Transplantation
|December 22, 2011
Summary
Human regulatory macrophages (M regs) are a promising cell therapy for organ transplantation. Advanced manufacturing and clinical studies show M regs are well-tolerated and effective in suppressing immune responses, paving the way for future applications.
Area of Science:
- Immunology
- Cell Therapy
- Transplantation Science
Background:
- Initial studies showed IFN-γ-stimulated macrophages prolonged allograft survival in animal models.
- Understanding of human regulatory macrophages (M regs) has evolved significantly.
Purpose of the Study:
- To consolidate scientific and technological understanding of M regs.
- To explore M regs as an adjunct immunosuppressive therapy in organ transplantation.
Main Methods:
- In vitro derivation and characterization of human M regs.
- Methodological advancements in M reg manufacture for purity and homogeneity.
- Clinical application and patient monitoring of M reg therapy.
Main Results:
- Detailed understanding of M reg derivation, phenotype, and T-cell suppression.
- Improved M reg manufacturing yielding a purer cell product.
- Clinical trials demonstrate M reg administration is well-tolerated and effective.
Conclusions:
- Human M regs represent a novel, well-defined medicinal product.
- M regs offer exciting therapeutic potential for organ transplantation.
- Further investigation of M regs in transplantation and other conditions is warranted.
